Millie
your market intelligence analyst
Search Results
54 results
Your search is now limited to «Tuberculosis» expert search.
European Respiratory Journal 10/17/2019 03:05
Increased tuberculosis (TB) disease risk has consistently been observed among solid organ transplant recipients [1, 2]. This may result from post-transplant immunosuppressive therapy, although underlying disease processes leading to transplant (including chronic kidney disease) are also associated with increased risk [3]. TB among transplant recipients is associated with increased risk of drug toxicity, drug–drug interactions, graft failure and mortality [4], and can lead to transmission to other vulnerable hospitalised patients. Consequently, global guidelines recommend systematic screening of patients undergoing solid organ transplant for latent tuberculosis infection (LTBI) [3].
More from European Respiratory Journal:
Medindia.com 10/12/2019 16:33
Nanomachines in the cell envelope During infection Mycobacterium tuberculosis, the main causative agent of tuberculosis, secretes a large number of effector proteins through type VII secretion systems - small nanomachines which are composed of proteins that reside in the cell envelope.
More from Medindia.com:
PubMed News (NIH) 10/05/2019
Contributor : Artem Grigorov Series Type : Expression profiling by high throughput sequencing Organism : Mycobacterium tuberculosis. We investigated the expression of MTS1338, a small non-coding RNA of Mycobacterium tuberculosis in bacterial cultures, and demonstrated its significant contribution to host-pathogen interactions.
More from PubMed News (NIH):
Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Tuberculosis, Date of authorisation: 07/04/2014, Revision: 7, Status: Authorised.
More from European Medicines Agency - EMEA (EU):
Vedanta Train and Air Ambulance Service Company recently shifted a patient suffering from serious Tuberculosis a contagious disease which is caused by the Mycobacterium tuberculosis bacteria.
More from Middle East North Africa Financial Network (MENAFN):
Lancet 09/13/2019 12:13
We must therefore move beyond the narrow view that tuberculosis is the problem of the world's poorest societies and recognise that the disease is a universal health problem for an interdependent global population.
More from Lancet:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications